SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 216 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19,323,467 | -26.2% | 512,967 | -3.6% | 0.00% | -33.3% |
| Q1 2024 | $26,201,136 | +352.8% | 532,327 | +235.8% | 0.01% | +500.0% |
| Q4 2023 | $5,786,127 | +723.3% | 158,524 | +421.5% | 0.00% | – |
| Q3 2023 | $702,756 | +7.8% | 30,396 | +22.3% | 0.00% | – |
| Q2 2023 | $651,856 | +41.5% | 24,861 | +38.9% | 0.00% | – |
| Q1 2023 | $460,642 | -12.3% | 17,896 | -11.3% | 0.00% | – |
| Q4 2022 | $525,038 | -8.5% | 20,186 | +0.2% | 0.00% | – |
| Q3 2022 | $574,000 | +21.9% | 20,137 | +5.2% | 0.00% | – |
| Q2 2022 | $471,000 | -54.9% | 19,142 | +3.5% | 0.00% | – |
| Q1 2022 | $1,045,000 | -71.2% | 18,498 | -68.4% | 0.00% | -100.0% |
| Q4 2021 | $3,631,000 | -32.5% | 58,584 | -30.9% | 0.00% | 0.0% |
| Q3 2021 | $5,381,000 | -38.7% | 84,807 | -20.4% | 0.00% | -50.0% |
| Q2 2021 | $8,777,000 | +21.8% | 106,499 | +8.7% | 0.00% | 0.0% |
| Q1 2021 | $7,209,000 | +2255.9% | 97,993 | +2221.6% | 0.00% | – |
| Q4 2020 | $306,000 | – | 4,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $429,009,000 | 24.30% |
| Consonance Capital Management LP | 1,201,399 | $88,387,000 | 9.42% |
| Boxer Capital, LLC | 2,075,905 | $152,724,000 | 5.18% |
| Perceptive Advisors | 4,849,912 | $356,808,000 | 4.51% |
| Orbimed Advisors | 6,186,307 | $455,127,000 | 4.26% |
| Samsara BioCapital, LLC | 169,852 | $12,496,000 | 2.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,262,075 | $92,851,000 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $41,094,000 | 0.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 137,672 | $10,129,000 | 0.78% |
| Affinity Asset Advisors, LLC | 27,000 | $1,986,000 | 0.67% |